These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24877083)

  • 1. Epigenetic control of autophagy by microRNAs in ovarian cancer.
    Titone R; Morani F; Follo C; Vidoni C; Mezzanzanica D; Isidoro C
    Biomed Res Int; 2014; 2014():343542. PubMed ID: 24877083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging roles of miRNA-mediated autophagy in ovarian cancer.
    Ding Y; Huang X; Ji T; Qi C; Gao X; Wei R
    Cell Death Dis; 2024 May; 15(5):314. PubMed ID: 38702325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Autophagy by MiRNAs and Their Emerging Roles in Tumorigenesis and Cancer Treatment.
    Chen L; Zhou Y; Sun Q; Zhou J; Pan H; Sui X
    Int Rev Cell Mol Biol; 2017; 334():1-26. PubMed ID: 28838537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of autophagy in ovarian cancer: a working hypothesis.
    Peracchio C; Alabiso O; Valente G; Isidoro C
    J Ovarian Res; 2012 Sep; 5(1):22. PubMed ID: 22974323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
    Ruan L; Xie Y; Liu F; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the Long Non-Coding RNAs and MicroRNAs Coregulation Networks in Ovarian Cancer Development: An Overview.
    López-Camarillo C; Ruíz-García E; Salinas-Vera YM; Silva-Cázares MB; Hernández-de la Cruz ON; Marchat LA; Gallardo-Rincón D
    Cells; 2021 Jun; 10(6):. PubMed ID: 34204094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.
    Yao D; Jiang Y; Gao S; Shang L; Zhao Y; Huang J; Wang J; Yang S; Chen L
    Cell Prolif; 2016 Oct; 49(5):541-53. PubMed ID: 27436709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.
    Wyman SK; Parkin RK; Mitchell PS; Fritz BR; O'Briant K; Godwin AK; Urban N; Drescher CW; Knudsen BS; Tewari M
    PLoS One; 2009; 4(4):e5311. PubMed ID: 19390579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant microRNAs in ovarian cancer.
    Zhang S; Lu Z; Unruh AK; Ivan C; Baggerly KA; Calin GA; Li Z; Bast RC; Le XF
    Mol Cancer Res; 2015 Mar; 13(3):393-401. PubMed ID: 25304686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Roles of Autophagy-Related MicroRNAs in Cancer.
    Shan C; Chen X; Cai H; Hao X; Li J; Zhang Y; Gao J; Zhou Z; Li X; Liu C; Li P; Wang K
    Int J Biol Sci; 2021; 17(1):134-150. PubMed ID: 33390839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of autophagy and its regulation by noncoding RNAs in ovarian cancer.
    Feng C; Yuan X
    Exp Biol Med (Maywood); 2023 Jun; 248(12):1001-1012. PubMed ID: 36803116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of autophagy with microRNAs and their potential therapeutic implications in human cancers.
    Jing Z; Han W; Sui X; Xie J; Pan H
    Cancer Lett; 2015 Jan; 356(2 Pt B):332-8. PubMed ID: 25304373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer.
    Kestens C; Siersema PD; van Baal JW
    World J Gastroenterol; 2016 Jan; 22(1):1-7. PubMed ID: 26755856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential ceRNA networks involved in autophagy suppression of pancreatic cancer caused by chloroquine diphosphate: A study based on differentially‑expressed circRNAs, lncRNAs, miRNAs and mRNAs.
    Wei DM; Jiang MT; Lin P; Yang H; Dang YW; Yu Q; Liao DY; Luo DZ; Chen G
    Int J Oncol; 2019 Feb; 54(2):600-626. PubMed ID: 30570107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA signatures in human ovarian cancer.
    Iorio MV; Visone R; Di Leva G; Donati V; Petrocca F; Casalini P; Taccioli C; Volinia S; Liu CG; Alder H; Calin GA; Ménard S; Croce CM
    Cancer Res; 2007 Sep; 67(18):8699-707. PubMed ID: 17875710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MARCH5 RNA promotes autophagy, migration, and invasion of ovarian cancer cells.
    Hu J; Meng Y; Zhang Z; Yan Q; Jiang X; Lv Z; Hu L
    Autophagy; 2017 Feb; 13(2):333-344. PubMed ID: 27875077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of microRNAs in ovarian cancer initiation and progression.
    Li SD; Zhang JR; Wang YQ; Wan XP
    J Cell Mol Med; 2010 Sep; 14(9):2240-9. PubMed ID: 20345848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-509-3p enhances platinum drug sensitivity in ovarian cancer.
    Niu L; Ni H; Hou Y; Du Q; Li H
    Gene; 2019 Feb; 686():63-67. PubMed ID: 30408550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.
    Nagaraja AK; Creighton CJ; Yu Z; Zhu H; Gunaratne PH; Reid JG; Olokpa E; Itamochi H; Ueno NT; Hawkins SM; Anderson ML; Matzuk MM
    Mol Endocrinol; 2010 Feb; 24(2):447-63. PubMed ID: 20081105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.